Suppression of p21Rac Signaling and Increased Innate Immunity Mediate Remission in Crohn's Disease

Kaushal Parikh, L Zhou, Rajesh Somasundaram, Gwenny Fuhler, Jasper Deuring, T Blokzijl, A Regeling, Ernst Kuipers, RK Weersma, Veerle Nuij, Maria Alves, Lauran Vogelaar, L Visser, Colin Haar, KK (Kausilia) Krishnadath, C.J. van der Woude, G Dijkstra, KN Faber, Maikel Peppelenbosch

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)


In inflammatory bowel disease (IBD), large areas of apparently healthy mucosa lie adjacent to ulcerated intestine. Knowledge of the mechanisms that maintain remission in an otherwise inflamed intestine could provide important clues to the pathogenesis of this disease and provide rationale for clinical treatment strategies. We used kinome profiling to generate comprehensive descriptions of signal transduction pathways in inflamed and noninflamed colonic mucosa in a cohort of IBD patients, and compared the results to non-IBD controls. We observed that p21Rac1 guanosine triphosphatase (GTPase) signaling was strongly suppressed in noninflamed colonic mucosa in IBD. This suppression was due to both reduced guanine nucleotide exchange factor activity and increased intrinsic GTPase activity. Pharmacological p21Rac1 inhibition correlated with clinical improvement in IBD, and mechanistically unrelated pharmacological p21Rac1 inhibitors increased innate immune functions such as phagocytosis, bacterial killing, and interleukin-8 production in healthy controls and patients. Thus, suppression of p21Rac activity assists innate immunity in bactericidal activity and may induce remission in IBD.
Original languageUndefined/Unknown
JournalScience Translational Medicine
Issue number233
Publication statusPublished - 2014

Research programs

  • EMC MM-04-20-01

Cite this